{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Irvine",
      "state": "CA",
      "country": "United States",
      "classification": "Class I",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "73626",
      "recalling_firm": "B. Braun Medical Inc",
      "address_1": "2525 McGaw Ave",
      "address_2": "N/A",
      "postal_code": "92614-5841",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide",
      "recall_number": "D-0094-2017",
      "product_description": "5% Dextrose Injection USP, 100mL in a 150 mL PAB container, Rx only, B. Braun Medical Inc. Irvine, CA 92614-5895 USA, NDC 00264-1510-32",
      "product_quantity": "57,408 units",
      "reason_for_recall": "Non-Sterility: fungal contamination due to leaking containers.",
      "recall_initiation_date": "20160325",
      "center_classification_date": "20161012",
      "termination_date": "20161012",
      "report_date": "20161019",
      "code_info": "Lot #:  J5J706, Exp. 10/31/2016"
    }
  ]
}